108
Participants
Start Date
March 21, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
June 30, 2026
9MW3011
Multiple dose
RECRUITING
Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin
RECRUITING
The Second Hospital of Tianjin Medical University, Tianjin
RECRUITING
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Mabwell (Shanghai) Bioscience Co., Ltd.
INDUSTRY